- Heart Failure Congress 2015:
Ivabradine is effective in chronic heart failure patients whatever the number of comorbidities - The American College of Cardiology 2015:
Ivabradine is effective in chronic heart failure patients with or without angina - Heart Failure Congress 2014:
The efficacy and safety of ivabradine are similar in diabetic and nondiabetic patients - ESC Congress 2013:
Ivabradine’s clinical benefits in CHF are maintained with or without renal dysfunction
The benefits and tolerability of ivabradine are similar irrespective of blood pressure
SHIFT is the basis of a prognostic model for heart failure patients
Ivabradine’s efficacy and safety are maintained with or without COPD